Compounds > rosiglitazone
Page last updated: 2024-08-25

rosiglitazone and Leucocythaemia

rosiglitazone has been researched along with Leucocythaemia in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, WM; Hou, W; Huang, MY; Lin, J; Sun, PH; Wang, F1
Rücker, G; Schumacher, M1
Andreeff, M; Chism, D; Collins, SJ; Elstner, E; Hu, W; Koeffler, HP; Konopleva, M; Kornblau, SM; McQueen, TJ; Schober, WD; Sudarikov, A; Tsao, T; Wang, RY; Younes, A1

Other Studies

3 other study(ies) available for rosiglitazone and Leucocythaemia

ArticleYear
5-Benzylidene-3,4-dihalo-furan-2-one derivatives inhibit human leukemia cancer cells through suppression of NF-κB and GSK-3β.
    Anti-cancer agents in medicinal chemistry, 2015, Volume: 15, Issue:6

    Topics: Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Furans; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; HeLa Cells; HT29 Cells; Humans; Leukemia; Membrane Potential, Mitochondrial; NF-kappa B; PPAR gamma; Proto-Oncogene Proteins c-bcl-2; Rosiglitazone; Thiazolidinediones; U937 Cells; Up-Regulation

2015
Simpson's paradox visualized: the example of the rosiglitazone meta-analysis.
    BMC medical research methodology, 2008, May-30, Volume: 8

    Topics: Child; Data Interpretation, Statistical; Electric Power Supplies; Humans; Leukemia; Meta-Analysis as Topic; Myocardial Infarction; Randomized Controlled Trials as Topic; Rosiglitazone; Sample Size; Statistics as Topic; Thiazolidinediones

2008
Peroxisome proliferator-activated receptor gamma and retinoid X receptor ligands are potent inducers of differentiation and apoptosis in leukemias.
    Molecular cancer therapeutics, 2004, Volume: 3, Issue:10

    Topics: Agar; Apoptosis; Blotting, Western; Cell Differentiation; Cell Line; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Cell Survival; Dimerization; Fibrinolytic Agents; Flow Cytometry; HL-60 Cells; Humans; Imidazoles; Immunologic Factors; Jurkat Cells; Leukemia; Ligands; Oleanolic Acid; Phagocytosis; Plasmids; PPAR gamma; Prostaglandin D2; Proto-Oncogene Proteins c-bcl-2; Receptors, Retinoic Acid; Retinoic Acid Receptor alpha; Retinoid X Receptors; RNA, Messenger; Rosiglitazone; Thiazolidinediones; Transcription, Genetic; Transcriptional Activation; Transfection; U937 Cells

2004